ScholarIQanswers from OpenAlex

Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial

PaperCitations, authors & open-access status

Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial have?

ScholarIQcitation count

Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial has 418 citations in the OpenAlex counts ScholarIQ stores.

When was Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial published?

ScholarIQyear

Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial has 2016 year in the ScholarIQ index.

What is the open-access status of Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial?

ScholarIQoa status

Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial has hybrid oa status in the ScholarIQ index.

What is the DOI of Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial?

ScholarIQdoi

The DOI for Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial is on the source record.

What is the PMID of Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial?

ScholarIQpmid

The PMID for Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial is on the source record.

What is the OpenAlex record for Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial?

ScholarIQopenalex

The OpenAlex for Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial